Geron Corporation has enrolled the first patient in its restarted clinical trial of human embryonic stem cells (hESC). The world’s …
US regulators have given the green light for the first human trial of an embryonic stem cell therapy to resume. …
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions

